Table 2 Clinical characteristics of schizophrenic patients with and without suicide attempts
Patients without SA (n = 71) | Patients with SA (n = 55) | p | |
|---|---|---|---|
Psychometric evaluation | |||
PANSS general | 35.25 ± 14.97 | 41.71 ± 15.86 | 0.021 |
PANSS positive | 14.70 ± 6.83 | 19.80 ± 8.88 | <0.001 |
PANSS negative | 17.52 ± 8.93 | 20.76 ± 9.02 | 0.046 |
CGI severity | 3.01 ± 1.61 | 3.31 ± 1.46 | <0.001 |
CGI overall improvement | 2.32 ± 1.20 | 2.22 ± 0.91 | 0.292 |
CGI therapeutic index | 4.94 ± 3.49 | 5.20 ± 3.34 | 0.590 |
EGF | 61.42 ± 18.21 | 53.27 ± 17.44 | 0.678 |
BPRS | 53.49 ± 23.53 | 69.24 ± 25.24 | 0.012 |
Calgary | 6.56 ± 10.11 | 8.31 ± 6.21 | 0.262 |
Type of schizophrenia | |||
Undifferentiated | 35 (47.88%) | 17 (30.90%) | 0.113 |
Paranoid | 23 (32.39%) | 25 (45.44%) | |
Disorganized | 13 (18.30%) | 13 (23.64%) | |
Neuroleptics | |||
Typical | 59 (83.1%) | 47 (85.5%) | 0.952 |
Typical and atypical | 12 (16.9%) | 8 (13.5%) | |
Doses of chlorpromazine | 990.07 ± 617.703 | 963.18 ± 652.663 | 0.814 |
Age at onset (year) | 25.99 ± 8.39 | 25.26 ± 8.98 | 0.643 |